Skip to content
HomeLatest newsJohnson & Johnson named a 2023 Fortune World’s Most Admired Company and ranked #1 on the Pharmaceutical Industry list.
A scientist looking into a microscope

Johnson & Johnson named a 2023 Fortune World’s Most Admired Company and ranked #1 on the Pharmaceutical Industry list.

A commitment to social responsibility and innovation are just two of the attributes that helped the company land a spot on the prestigious list once again.

Since its founding in 1886, Johnson & Johnson has been dedicated to changing the trajectory of health for everyone, everywhere. And that dedication continues to be recognized.

For the 21st year in a row, Fortune has named Johnson & Johnson as a Top 50 All-Star on its list of the World’s Most Admired Companies. The company ranked #1 on the Pharmaceutical Industry list for the tenth consecutive year.

The Makings of a World’s Most Admired Company

To compile its list of best-regarded companies in 52 industries worldwide, as well as the top 50 most-admired overall, Fortune—in collaboration with consulting firm Korn Ferry—asked executives, directors and analysts to rate enterprises in their own industry on the basis of nine criteria. Those include investment value, quality of management, social responsibility and ability to attract and retain talented people.

Johnson & Johnson is one of only five companies that have made the list every year since Fortune started it 25 years ago. The recognition is particularly rewarding since much of the judging criteria aligns with values outlined in Our Credo, Johnson & Johnson’s guiding mission statement. For example: “We are responsible to the communities in which we live and work and to the world community as well.”

The judging criteria aligns with values outlined in Our Credo, Johnson & Johnson’s guiding mission statement. For example: “We are responsible to the communities in which we live and work and to the world community as well.

That responsibility includes tackling some of the world’s most pressing unmet healthcare needs, such as a commitment to innovating treatments for deadly diseases, working to advance health equity across the globe and improving environmental health—just to name a few.
The company is honored to be included among Fortune’s World’s Most Admired Companies once again.

More ways Johnson & Johnson is helping change the world

Read the 2021 Health for Humanity Report to see how the company is putting health and wellness in reach of people everywhere.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.